CDK4 - middle region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-CDK4 - middle region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CDK4 - middle region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G1/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G1 phase. Hypophosphorylates RB1 in early G1 phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear transloc |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the middle region of rat CDK4 |
| Other Names | [cyclin-dependent kinase 4; Cyclin-dependent kinase 4; cyclin-dependent kinase 4; cyclin-dependent kinase 4; Cell division protein kinase 4; PSK-J3] |
| Gene, Accession # | [CDK4], Gene ID: 94201, NCBI: NP_446045.1, UniProt: P35426 |
| Catalog # | MBS3223543 |
| Price | $335 |
| Order / More Info | CDK4 - middle region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies